Literature DB >> 19320321

Improving care in ovarian cancer: the role of a clinico-pathological meeting.

Prasanth Ganesan1, Lalit Kumar, Roopa Hariprasad, Aarti Gupta, R Dawar, M Vijayaraghavan.   

Abstract

BACKGROUND: We assessed the impact of clinico-pathological meetings on the diagnosis and management of patients with ovarian cancer.
METHODS: Between January 2005 and December 2006, about 400 patients of suspected or confirmed ovarian cancer were evaluated in the 'Gynaecology Tumour Clinic'. Of these, 108 cases were referred for discussion in the weekly clinico-pathology meeting for various indications. These cases were retrospectively analysed regarding their initial clinical and pathological diagnosis, the indication for referring the case for discussion in the meeting and the impact this had on the overall management. Alterations in diagnosis, which impacted management, were classified as 'major changes' and those, which did not, were called 'minor changes'.
RESULTS: Ninety-one of the 108 cases discussed were available for analysis; 75.8% of cases were initially diagnosed as epithelial ovarian cancers. In 48 of 91 cases (52%), there was an alteration in the diagnosis as a direct result of discussion in the meeting, mainly after clarifications regarding histological grading in 34 cases. Of the remaining 14 cases, 3 had a change in histopathological diagnosis; 2 cases, which were initially labelled as undifferentiated tumours, had their diagnosis clarified; and in the remaining 9 cases, in which the primary site was not known, a possible primary site could be assigned (with the help of clinical, radiological and pathological inputs). Among the 14 cases with alterations other than grading, the change was contributed by slide review alone in 7 cases and in the rest by a combination of slide review and clinical inputs. As a direct outcome of the meeting, 20 of 91 cases (22%) had their management plan modified (major change).
CONCLUSION: The practice of conducting weekly clinicopathological meetings has a major impact on the management of cases of ovarian cancer.

Entities:  

Mesh:

Year:  2008        PMID: 19320321

Source DB:  PubMed          Journal:  Natl Med J India        ISSN: 0970-258X            Impact factor:   0.537


  4 in total

1.  Collaborative case conferences in rectal cancer: case series in a tertiary care centre.

Authors:  C Eskicioglu; S Forbes; S Tsai; V Francescutti; A Coates; V Grubac; R Sonnadara; M Simunovic
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

2.  Decision-Making in Multidisciplinary Tumor Boards in Breast Cancer Care - An Observational Study.

Authors:  Barbara Schellenberger; Annika Diekmann; Christian Heuser; Nikoloz Gambashidze; Nicole Ernstmann; Lena Ansmann
Journal:  J Multidiscip Healthc       Date:  2021-06-01

3.  Activation of the LKB1‑SIK1 signaling pathway inhibits the TGF‑β‑mediated epithelial‑mesenchymal transition and apoptosis resistance of ovarian carcinoma cells.

Authors:  Bo Hong; Jianmei Zhang; Wenlan Yang
Journal:  Mol Med Rep       Date:  2017-12-08       Impact factor: 2.952

4.  Analysis of management decisions and outcomes of a weekly multidisciplinary pediatric tumor board meeting in Uganda.

Authors:  Paul E George; Geriga Fahdil; Israel Luutu; Alfred Bulamu; John Sekabira; Nasser Kakembo; Susan Nabadda; Sam Kalungi; Joyce B Kambugu
Journal:  Future Sci OA       Date:  2019-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.